|
88
|
299
|
9at0A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (s-enantiomer) |
|
85
|
300
|
9at4A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylbicyclo[2.2.1]heptane 2-pyrrolidone inhibitor |
|
88
|
300
|
9aszA |
Crystal structure of sars-cov-2 3cl protease in complex with a phenylethyl 2-pyrrolidone inhibitor |
|
84
|
300
|
9asvA |
Crystal structure of sars-cov-2 3cl protease in complex with a benzyl 2-pyrrolidone inhibitor |
|
85
|
299
|
9asyA |
Crystal structure of sars-cov-2 3cl protease in complex with a m-chlorobenzyl 2-pyrrolidone inhibitor |
|
83
|
298
|
9at3A |
Crystal structure of sars-cov-2 3cl protease in complex with an ethylcyclohexyl 2-pyrrolidone inhibitor |
|
84
|
305
|
9atiA |
Crystal structure of mers 3cl protease in complex with a racemic bicyclo[2.2.1]heptenyl-methyl 2-pyrrolidone inhibitor |
|
85
|
305
|
9atfA |
Crystal structure of mers 3cl protease in complex with a 1-methyl-4,4-difluorocyclohexyl 2-pyrrolidone inhibitor |
|
85
|
306
|
9atdA |
Crystal structure of mers 3cl protease in complex with a ethylcyclohexyl 2-pyrrolidone inhibitor (s-enantiomer) inhibitor |
|
88
|
306
|
9ataA |
Crystal structure of mers 3cl protease in complex with a phenylethyl 2-pyrrolidone inhibitor |
|
85
|
303
|
9at6A |
Crystal structure of sars-cov-2 3cl protease in complex with a methylbicyclo[2.2.1]heptene 2-pyrrolidone inhibitor |
|
82
|
306
|
9atsA |
Crystal structure of mers 3cl protease in complex with a methylcyclohexyl 2-pyrrolidone inhibitor (s-enantiomer) |
|
84
|
303
|
9at5A |
Crystal structure of sars-cov-2 3cl protease in complex with a 1-methyl-4,4-difluorocyclohexyl 2-pyrrolidone inhibitor |
|
88
|
301
|
9at7A |
Crystal structure of sars-cov-2 3cl protease in complex with a 2,2-difluoro-5-methylbenzo[1,3]dioxole 2-pyrrolidone inhibitor |
|
86
|
305
|
9atjA |
Crystal structure of mers 3cl protease in complex with a m-chlorobenzyl 2-pyrrolidone inhibitor |
|
43
|
244
|
8tccA |
Gtp cyclohydrolase-ib with dehydrocostus lactone |
|
160
|
524
|
9blgA |
Crystal structure of non-receptor protein tyrosine phosphatase shp2 in complex with pf-07284892 |
|
215
|
675
|
9cbjA |
Crystal structure of danio rerio histone deacetylase 10 in complex with p-aminopropyl phenylthioketone |
|
218
|
676
|
9cbiA |
Crystal structure of danio rerio histone deacetylase 10 in complex with p-aminoethyl phenylthioketone |
|
206
|
675
|
9cbhA |
Crystal structure of danio rerio histone deacetylase 10 in complex with p-aminomethyl phenylthioketone |
|
217
|
676
|
9cbfA |
Crystal structure of danio rerio histone deacetylase 10 in complex with m-aminomethyl phenylthioketone |
|
103
|
295
|
9c55A |
Crystal structure of human ptpn2 in complex with active site inhibitor |
|
143
|
357
|
9cbkA |
Crystal structure of danio rerio histone deacetylase 6 in complex with p-aminomethyl phenylthioketone |
|
212
|
676
|
9cbgA |
Crystal structure of danio rerio histone deacetylase 10 in complex with m-aminoethyl phenylthioketone |
|
94
|
279
|
9c56A |
Crystal structure of human ptpn2 in complex with allosteric inhibitor |
|
55
|
248
|
9azkA |
Macrocyclic inhibitors targeting the prime site of the fibrinolytic serine protease plasmin |
|
55
|
223
|
8xnjA |
Crystal structure of trypsin in-complex with arginine |
|
55
|
223
|
8xniA |
Crystal structure of trypsin in-complex with e-64 |
|
121
|
323
|
8wkfA |
Rational design of highly selective pde5 inhibitors for the treatment of idiopathic pulmonary fibrosis |
|
85
|
301
|
8w1uA |
Sars-cov-2 main protease bound to non-covalent lead molecule nz-804 |
|
88
|
306
|
8w1tA |
Sars-cov-2 main protease bound to a non-covalent non-peptidic hts hit |
|
123
|
323
|
8wkgA |
Rational design of highly selective pde5 inhibitors for the treatment of idiopathic pulmonary fibrosis |
|
85
|
249
|
8vauA |
Nicotinamide riboside and cd38: covalent inhibition and live-cell labeling |
|
139
|
529
|
8fvpB |
Pcsk9 in complex with an inhibitor |
|
21
|
92
|
8fvoA |
Pcsk9 in complex with an inhibitor |
|
20
|
92
|
8fvnA |
Pcsk9 in complex with an inhibitor |
|
20
|
92
|
8fvqA |
Pcsk9 in complex with an inhibitor |
|
23
|
92
|
8fvmA |
Pcsk9 in complex with an inhibitor |
|
140
|
529
|
8fvoB |
Pcsk9 in complex with an inhibitor |
|
137
|
529
|
8fvnB |
Pcsk9 in complex with an inhibitor |
|
0
|
5
|
8fvmC |
Pcsk9 in complex with an inhibitor |
|
141
|
529
|
8fvqB |
Pcsk9 in complex with an inhibitor |
|
141
|
529
|
8fvlB |
Pcsk9 in complex with an inhibitor |
|
138
|
529
|
8fpoB |
Pcsk9 in complex with an inhibitor |
|
21
|
92
|
8fpoA |
Pcsk9 in complex with an inhibitor |
|
21
|
92
|
8fpqA |
Pcsk9 in complex with an inhibitor |
|
0
|
6
|
8fvqL |
Pcsk9 in complex with an inhibitor |
|
20
|
92
|
8fvlA |
Pcsk9 in complex with an inhibitor |
|
140
|
530
|
8fpqB |
Pcsk9 in complex with an inhibitor |
|
142
|
530
|
8fvmB |
Pcsk9 in complex with an inhibitor |
